Advanced search
Publication Cover
Current Medical Research and Opinion Volume 20, 2004 - Issue sup1
Submit an article Journal homepage
243
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Comparing the Long-term Cost-effectiveness of Repaglinide Plus Metformin Versus Nateglinide Plus Metformin in Type 2 Diabetes Patients with Inadequate Glycaemic Control: An Application of the CORE Diabetes Model in Type 2 Diabetes

Andrew J. Palmer CORE – Center for Outcomes Research, Binningen/Basel, SwitzerlandCorrespondence[email protected]
,
Stéphane Roze CORE – Center for Outcomes Research, Binningen/Basel, Switzerland
,
Morten Lammert CORE – Center for Outcomes Research, Binningen/Basel, Switzerland
,
William J. Valentine CORE – Center for Outcomes Research, Binningen/Basel, Switzerland
,
Michael E. Minshall CORE-USA, LLC, Fishers, Indiana, USA
,
Lars Nicklasson Novo Nordisk Pharmaceuticals Inc., Princeton, NJ, USA
,
Mari-Anne Gall Novo Nordisk A/S, Bagsvaerd, Denmark
&
Giatgen A. Spinas Department of Endocrinology and Diabetes, University Hospital Zürich, Switzerland
 show all
Pages S41-S51 | Accepted 26 May 2004, Published online: 02 Aug 2004

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Christian Becker, Astrid Langer & Reiner Leidl. (2011) The quality of three decision-analytic diabetes models: a systematic health economic assessment. Expert Review of Pharmacoeconomics & Outcomes Research 11:6, pages 751-762.
Read now
Y. Yi, Z. Philips, G. Bergman & K. Burslem. (2010) Economic models in type 2 diabetes. Current Medical Research and Opinion 26:9, pages 2105-2118.
Read now
Robert G Moses. (2010) Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin. Expert Review of Endocrinology & Metabolism 5:3, pages 331-342.
Read now
Louis S. Matza, Nicole Yurgin, Kristina S. Boye, Karen Malley & Jodi M. Shorr. (2007) Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change. Current Medical Research and Opinion 23:9, pages 2051-2062.
Read now

Articles from other publishers (9)

Katherine Ogurtsova, Thomas L. Heise, Ute Linnenkamp, Charalabos-Markos Dintsios, Stefan K. Lhachimi & Andrea Icks. (2017) External validation of type 2 diabetes computer simulation models: definitions, approaches, implications and room for improvement—a protocol for a systematic review. Systematic Reviews 6:1.
Crossref
Xinyang Hua, Thomas Wai-Chun Lung, Andrew Palmer, Lei Si, William H. Herman & Philip Clarke. (2016) How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review. PharmacoEconomics 35:3, pages 319-329.
Crossref
Yue Zhong, Pei-Jung Lin, Joshua T. Cohen, Aaron N. Winn & Peter J. Neumann. (2015) Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence. Value in Health 18:2, pages 308-314.
Crossref
John W. RichardIIIIIIPhilip Raskin. (2011) Updated Review: Improved Glycemic Control with Repaglinide-Metformin in Fixed Combination for Patients with Type 2 Diabetes. Clinical Medicine Insights: Endocrinology and Diabetes 4, pages CMED.S5094.
Crossref
Silvia Bustacchini, Andrea Corsonello, Graziano Onder, Enrico Eugenio Guffanti, Flavio Marchegiani, Angela Marie Abbatecola & Fabrizia Lattanzio. (2009) Pharmacoeconomics and Aging. Drugs & Aging 26:Supplement 1, pages 75-87.
Crossref
Sandra L. Tunis. (2009) A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US. PharmacoEconomics 27:9, pages 735-744.
Crossref
Elise M. Pelletier, Paula J. Smith, Kristina S. Boye, Derek A. Misurski, Sandra L. Tunis & Michael E. Minshall. (2012) Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting. Applied Health Economics and Health Policy 6:2-3, pages 103-112.
Crossref
P. Raskin. (2008) Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes. Diabetes, Obesity and Metabolism 0:0, pages 080520205432340-???.
Crossref
Todd P. Gilmer, Stéphane Roze, William J. Valentine, Katrina Emy-Albrecht, Joshua A. Ray, David Cobden, Lars Nicklasson, Athena Philis-Tsimikas & Andrew J. Palmer. (2007) Cost-Effectiveness of Diabetes Case Management for Low-Income Populations. Health Services Research 42:5, pages 1943-1959.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.